Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430

BACKGROUND. Interest in oral agents for the treatment of metastatic breast cancer (MBC) has increased because many patients prefer oral to i.v. regimens. We evaluated a simple oral combination of capecitabine with cyclophosphamide (CPA) for MBC. METHODS. The trial was designed to determine whether o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schott, Anne F., Barlow, William E., Albain, Kathy S., Chew, Helen K., Wade, James L., Lanier, Keith S., Lew, Danika L., Hayes, Daniel F., Gralow, Julie R., Livingston, Robert B., Hortobagyi, Gabriel N.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2012
Matèries:
Breast Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286166/
https://ncbi.nlm.nih.gov/pubmed/22267853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0235
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars